カテゴリー： QYResearch, 世界

B型肝炎治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Hepatitis B Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18539）・商品コード：DATA909X18539
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、B型肝炎治療の世界市場について調査・分析し、B型肝炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（急性、慢性）、用途別（免疫調節薬、抗ウイルス薬）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のB型肝炎治療市場動向
・主要企業別マーケットシェア
・B型肝炎治療の種類別市場規模2014-2019
（急性、慢性）
・B型肝炎治療の用途別市場規模2014-2019
（免疫調節薬、抗ウイルス薬）
・B型肝炎治療の北米市場：主要企業・種類別/用途別市場規模
・B型肝炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・B型肝炎治療の中国市場：主要企業・種類別/用途別市場規模
・B型肝炎治療の日本国内市場：主要企業・種類別/用途別市場規模
・B型肝炎治療の東南アジア市場：主要企業・種類別/用途別市場規模
・B型肝炎治療のインド市場：主要企業・種類別/用途別市場規模
・B型肝炎治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Accord Healthcare Inc.、Apotex Corp.、Arbutus Biopharma、Bristol-Myers Squibb Company、Gilead Sciences、GlaxoSmithKline、Lupin Pharmaceuticals、Merck & Co., Inc.、Par Pharmaceutical、Teva Pharmaceuticals、Zydus Pharmaceuticals）
・B型肝炎治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

It means a treatment of Hepatitis B—— contagious liver infection that can be long lasting. In 2018, the global Hepatitis B Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hepatitis B Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Accord Healthcare Inc.
Apotex Corp.
Arbutus Biopharma
Bristol-Myers Squibb Company
Gilead Sciences
GlaxoSmithKline
Lupin Pharmaceuticals
Merck & Co., Inc.
Par Pharmaceutical
Teva Pharmaceuticals
Zydus Pharmaceuticals

Market segment by Type, the product can be split into
Acute
Chronic

Market segment by Application, split into
Immune Modulator Drugs
Antiviral Drugs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hepatitis B Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hepatitis B Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hepatitis B Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hepatitis B Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Acute
1.4.3 Chronic
1.5 Market by Application
1.5.1 Global Hepatitis B Treatment Market Share by Application (2019-2025)
1.5.2 Immune Modulator Drugs
1.5.3 Antiviral Drugs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hepatitis B Treatment Market Size
2.2 Hepatitis B Treatment Growth Trends by Regions
2.2.1 Hepatitis B Treatment Market Size by Regions (2019-2025)
2.2.2 Hepatitis B Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Hepatitis B Treatment Market Size by by Players
3.1.1 Global Hepatitis B Treatment Revenue by by Players (2014-2019)
3.1.2 Global Hepatitis B Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis B Treatment Key Players Head office and Area Served
3.3 Key Players Hepatitis B Treatment Product/Solution/Service
3.4 Date of Enter into Hepatitis B Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hepatitis B Treatment Market Size by Type (2014-2019)
4.2 Global Hepatitis B Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Hepatitis B Treatment Market Size (2014-2019)
5.2 Hepatitis B Treatment Key Players in North America
5.3 North America Hepatitis B Treatment Market Size by Type
5.4 North America Hepatitis B Treatment Market Size by Application

6 Europe
6.1 Europe Hepatitis B Treatment Market Size (2014-2019)
6.2 Hepatitis B Treatment Key Players in Europe
6.3 Europe Hepatitis B Treatment Market Size by Type
6.4 Europe Hepatitis B Treatment Market Size by Application

7 China
7.1 China Hepatitis B Treatment Market Size (2014-2019)
7.2 Hepatitis B Treatment Key Players in China
7.3 China Hepatitis B Treatment Market Size by Type
7.4 China Hepatitis B Treatment Market Size by Application

8 Japan
8.1 Japan Hepatitis B Treatment Market Size (2014-2019)
8.2 Hepatitis B Treatment Key Players in Japan
8.3 Japan Hepatitis B Treatment Market Size by Type
8.4 Japan Hepatitis B Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hepatitis B Treatment Market Size (2014-2019)
9.2 Hepatitis B Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hepatitis B Treatment Market Size by Type
9.4 Southeast Asia Hepatitis B Treatment Market Size by Application

10 India
10.1 India Hepatitis B Treatment Market Size (2014-2019)
10.2 Hepatitis B Treatment Key Players in India
10.3 India Hepatitis B Treatment Market Size by Type
10.4 India Hepatitis B Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Hepatitis B Treatment Market Size (2014-2019)
11.2 Hepatitis B Treatment Key Players in Central & South America
11.3 Central & South America Hepatitis B Treatment Market Size by Type
11.4 Central & South America Hepatitis B Treatment Market Size by Application

12 International Players Profiles
12.1 Accord Healthcare Inc.
12.1.1 Accord Healthcare Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hepatitis B Treatment Introduction
12.1.4 Accord Healthcare Inc. Revenue in Hepatitis B Treatment Business (2014-2019))
12.1.5 Accord Healthcare Inc. Recent Development
12.2 Apotex Corp.
12.2.1 Apotex Corp. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hepatitis B Treatment Introduction
12.2.4 Apotex Corp. Revenue in Hepatitis B Treatment Business (2014-2019)
12.2.5 Apotex Corp. Recent Development
12.3 Arbutus Biopharma
12.3.1 Arbutus Biopharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hepatitis B Treatment Introduction
12.3.4 Arbutus Biopharma Revenue in Hepatitis B Treatment Business (2014-2019)
12.3.5 Arbutus Biopharma Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hepatitis B Treatment Introduction
12.4.4 Bristol-Myers Squibb Company Revenue in Hepatitis B Treatment Business (2014-2019)
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 Gilead Sciences
12.5.1 Gilead Sciences Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hepatitis B Treatment Introduction
12.5.4 Gilead Sciences Revenue in Hepatitis B Treatment Business (2014-2019)
12.5.5 Gilead Sciences Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hepatitis B Treatment Introduction
12.6.4 GlaxoSmithKline Revenue in Hepatitis B Treatment Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Lupin Pharmaceuticals
12.7.1 Lupin Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hepatitis B Treatment Introduction
12.7.4 Lupin Pharmaceuticals Revenue in Hepatitis B Treatment Business (2014-2019)
12.7.5 Lupin Pharmaceuticals Recent Development
12.8 Merck & Co., Inc.
12.8.1 Merck & Co., Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hepatitis B Treatment Introduction
12.8.4 Merck & Co., Inc. Revenue in Hepatitis B Treatment Business (2014-2019)
12.8.5 Merck & Co., Inc. Recent Development
12.9 Par Pharmaceutical
12.9.1 Par Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hepatitis B Treatment Introduction
12.9.4 Par Pharmaceutical Revenue in Hepatitis B Treatment Business (2014-2019)
12.9.5 Par Pharmaceutical Recent Development
12.10 Teva Pharmaceuticals
12.10.1 Teva Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hepatitis B Treatment Introduction
12.10.4 Teva Pharmaceuticals Revenue in Hepatitis B Treatment Business (2014-2019)
12.10.5 Teva Pharmaceuticals Recent Development
12.11 Zydus Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Hepatitis B Treatment Key Market Segments
Table Key Players Hepatitis B Treatment Covered
Table Global Hepatitis B Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Acute Figures
Table Key Players of Acute
Figuer Chronic Figures
Table Key Players of Chronic
Table Global Hepatitis B Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Hepatitis B Treatment Market Share by Application in 2018 & 2025
Figure Immune Modulator Drugs Case Studies
Figure Antiviral Drugs Case Studies
Figure Hepatitis B Treatment Report Years Considered
Figure Global Hepatitis B Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hepatitis B Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Hepatitis B Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Hepatitis B Treatment Market Share by Regions 2014-2019
Figure Global Hepatitis B Treatment Market Share by Regions 2014-2019
Figure Global Hepatitis B Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Hepatitis B Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Hepatitis B Treatment Market Share by by Players (2014-2019)
Figure Global Hepatitis B Treatment Market Share by by Players in 2018
Table Global Hepatitis B Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hepatitis B Treatment Product/Solution/Service
Table Date of Enter into Hepatitis B Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis B Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Hepatitis B Treatment Market Size Share by Type (2014-2019)
Figure Global Hepatitis B Treatment Market Size Market Share by Type (2014-2019)
Table Global Hepatitis B Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Hepatitis B Treatment Market Size Share by Application (2014-2019)
Figure Global Hepatitis B Treatment Market Size Market Share by Application (2014-2019)
Figure Global Hepatitis B Treatment Revenue Market Share by Application in 2018
Figure North America Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Hepatitis B Treatment Market Share (2018-2019)
Table North America Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Hepatitis B Treatment Market Share by Type 2014-2019
Table North America Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Hepatitis B Treatment Market Share by Application 2014-2019
Figure Europe Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Hepatitis B Treatment Market Share (2018-2019)
Table Europe Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Hepatitis B Treatment Market Share by Type 2014-2019
Table Europe Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Hepatitis B Treatment Market Share by Application 2014-2019
Figure China Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Hepatitis B Treatment Market Share (2018-2019)
Table China Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table China Hepatitis B Treatment Market Share by Type 2014-2019
Table China Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table China Hepatitis B Treatment Market Share by Application 2014-2019
Figure Japan Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Hepatitis B Treatment Market Share (2018-2019)
Table Japan Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Hepatitis B Treatment Market Share by Type 2014-2019
Table Japan Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Hepatitis B Treatment Market Share by Application 2014-2019
Figure Southeast Asia Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hepatitis B Treatment Market Share (2018-2019)
Table Southeast Asia Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Hepatitis B Treatment Market Share by Type 2014-2019
Table Southeast Asia Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Hepatitis B Treatment Market Share by Application 2014-2019
Figure India Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Hepatitis B Treatment Market Share (2018-2019)
Table India Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table India Hepatitis B Treatment Market Share by Type 2014-2019
Table India Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table India Hepatitis B Treatment Market Share by Application 2014-2019
Figure Central & South America Hepatitis B Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hepatitis B Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hepatitis B Treatment Market Share (2018-2019)
Table Central & South America Hepatitis B Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Hepatitis B Treatment Market Share by Type 2014-2019
Table Central & South America Hepatitis B Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Hepatitis B Treatment Market Share by Application 2014-2019
Table Accord Healthcare Inc. Company Details
Table Accord Healthcare Inc. Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Accord Healthcare Inc. Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Accord Healthcare Inc. Recent Development
Table Apotex Corp. Company Details
Table Apotex Corp. Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Apotex Corp. Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Apotex Corp. Recent Development
Table Arbutus Biopharma Company Details
Table Arbutus Biopharma Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Arbutus Biopharma Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Arbutus Biopharma Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Gilead Sciences Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Lupin Pharmaceuticals Company Details
Table Lupin Pharmaceuticals Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Lupin Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Lupin Pharmaceuticals Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Par Pharmaceutical Company Details
Table Par Pharmaceutical Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Par Pharmaceutical Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Par Pharmaceutical Recent Development
Table Teva Pharmaceuticals Company Details
Table Teva Pharmaceuticals Revenue in Hepatitis B Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceuticals Revenue Growth Rate in Hepatitis B Treatment Business (2014-2019)
Table Teva Pharmaceuticals Recent Development
Table Zydus Pharmaceuticals Company Details
Table Global Hepatitis B Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Hepatitis B Treatment Market Size Share by Regions (2019-2025)
Figure Global Hepatitis B Treatment Market Size Share by Regions in 2025
Figure North America Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hepatitis B Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Hepatitis B Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Hepatitis B Treatment Market Size by Product (2019-2025)
Figure Global Hepatitis B Treatment Market Size by Product in 2025
Table Global Hepatitis B Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Hepatitis B Treatment Market Size by Application (2019-2025)
Figure Global Hepatitis B Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Accord Healthcare Inc.、Apotex Corp.、Arbutus Biopharma、Bristol-Myers Squibb Company、Gilead Sciences、GlaxoSmithKline、Lupin Pharmaceuticals、Merck & Co., Inc.、Par Pharmaceutical、Teva Pharmaceuticals、Zydus Pharmaceuticals

★調査レポート[B型肝炎治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18539)販売に関する免責事項を必ずご確認ください。
★調査レポート[B型肝炎治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 自己免疫性肝炎治療の世界市場：規模・現状・予測2019-2025
    DATA909X18186 / QYResearch / 2019年11月25日 / ※当調査レポートでは、自己免疫性肝炎治療の世界市場について調査・分析し、自己免疫性肝炎治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の自己免疫性肝炎治療市場動向 ・主要企業別マーケットシェア ・自己免疫性肝炎治療の種類別市場規模2014-2019 （テーブル製品、インジェクト製品、その他） ・自己免疫性肝炎治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・自己免疫性肝炎治療の北米市場：主要企業・種類別/用途別市場規模 ・自己免疫性肝炎治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Autoimmune Hepatitis is a serious condition that may worsen over time if not treated. Autoimmune Hepatitis can lead to cirrhosis and liver failure.Autoimmune hepatitis is a disease in which the body's own immune system attacks the liver and causes it to become inflamed.In 2018, the global Autoimmune Hepatitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Autoimmune Hepatitis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autoimmune Hepatitis...

    • ◆H&Iグローバルリサーチのお客様（例）◆